期刊论文详细信息
| Molbank | |
| 1-(3-Amino-1-phenylpropyl)-3-(2-fluorophenyl)-1,3-dihydro-2H-benzimidazol-2-one | |
| Catharina Neudorfer1  Nadine Eberherr1  Karem Shanab1  Wolfgang Holzer1  Christina Rami-Mark1  Markus Mitterhauser1  Wolfgang Wadsak1  | |
| [1] 1Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria 2Division of Drug Synthesis, Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria | |
| 关键词: NET; PET; FAPPI; | |
| DOI : 10.3390/M867 | |
| 来源: mdpi | |
PDF
|
|
【 摘 要 】
Starting from 1-(2-fluorophenyl)-1,3-dihydro-2H-benzimidazol-2-one (1) and (1-bromo-3-chloropropyl)benzene (2), the target compound 3, which represents a precursor for future radiolabeling, is prepared in a three-step synthesis.
【 授权许可】
CC BY
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202003190007509ZK.pdf | 666KB |
PDF